Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-09-19T00:15:57.670Z.
Consensus retrieved: 2026-09-13T23:42:47.298Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-19T00:15:57.670Z.
Quote observation: 2026-09-18T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9edfc78ac10ef3c00dfd6e8891c60c5ddca660cc4cfb74c64a12c551c30ed6c4
Forward PE Ratio (N/A) = Dated Quote Price ($18.16) / Consensus Forward EPS ($-1.88)
FORWARD PE RATIO
N/A
Shoulder Innovations, Inc.
Market Cap
$376.61M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | N/A |
| NRC Health (NRC)vs › | $463.35M | 23.36 |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 6.24 |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 58.26 |
| Doximity, Inc. (DOCS)vs › | $4.88B | 19.40 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 19.84 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $18.16, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.88 | $-1.92 – $-1.85 | 2 | n/m |
| 2027-12-31 | $-1.57 | $-1.60 – $-1.55 | 2 | n/m |
| 2028-12-31 | $-1.43 | $-2.40 – $-1.00 | 4 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
